| Annual Financials | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM |
Revenue  | 58 | 161 | 272 | 202 | 201 | 167 | 166 | 218 | 245 | 319 | 364 | 0 |
| Expenses | 56 | 158 | 264 | 195 | 197 | 163 | 161 | 209 | 237 | 309 | 348 | 0 |
| EBITDA | 1 | 4 | 8 | 7 | 5 | 4 | 5 | 9 | 9 | 10 | 16 | 0 |
| Operating Profit % | 2 % | 2 % | 3 % | 3 % | 2 % | 3 % | 3 % | 4 % | 3 % | 3 % | 4 % | 0 % |
| Depreciation | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 3 | 3 | 0 |
| Interest | 1 | 1 | 2 | 2 | 3 | 2 | 2 | 3 | 2 | 2 | 4 | 0 |
| Profit Before Tax | 1 | 3 | 6 | 4 | 1 | 2 | 2 | 5 | 5 | 6 | 10 | 0 |
| Tax | 0 | 1 | 2 | 1 | 0 | 0 | 1 | 1 | 2 | 1 | 3 | 0 |
| Net Profit | 0 | 2 | 4 | 3 | 1 | 1 | 1 | 4 | 4 | 4 | 7 | 0 |
| EPS in ₹ | 3.98 | 18.53 | 37.41 | 5.66 | 2.02 | 2.15 | 2.87 | 6.72 | 5.72 | 5.97 | 10.55 | 0.00 |
Aristo Bio-Tech & Lifescience
Aristo Bio-Tech & Lifescience
104.35
-5.45
(-4.96%)
Market Cap
71.04 Cr
PE Ratio
10.41
Volume
1,600.00
Day High - Low
104.35 - 104.35
52W High-Low
143.55 - 74.30
Key Fundamentals
Market Cap
71.04 Cr
EPS
10.55
PE Ratio
10.41
PB Ratio
1.68
Book Value
65.39
EBITDA
16.05
Dividend Yield
0.55 %
Industry
Chemicals Sector
Pesticides & Agrochemicals Return on Equity
10.88
Debt to Equity
0.60
Actual
Company News
View All News
Aristo Bio-Tech and Lifescience reported a 74.5% rise in net profit to ₹718.26 lakh for FY26. Revenue increased 14.3% to ₹3,637.17 lakh.
Aristo Bio-Tech and Lifescience Limited submitted the SDD compliance certificate for FY26 to NSE, confirming the capture of four UPSI events and adherence to SEBI PIT Regulations.
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
642.00 | #1 54,195.67 | 24.57 | #1 51,839.00 | 10.01 | #1 1,914 | 19.93 | 51.72 | |
2,726.10 | 41,359.88 | 31.48 | 6,713.70 | -19.33 | 1,361 | -39.43 | 36.44 | |
478.65 | 23,891.61 | 44.33 | 3,238.32 | -0.93 | 545 | 11.52 | 56.42 | |
4,410.00 | 19,819.46 | 28.70 | 5,593.10 | 7.89 | 568 | 13.12 | 42.77 | |
909.20 | 8,202.85 | #1 12.18 | 5,267.59 | 20.28 | 716 | 56.53 | 41.39 | |
1,099.90 | 4,958.16 | 16.56 | 2,071.30 | 15.49 | 297 | 27.97 | 48.22 | |
231.51 | 4,502.15 | 31.33 | 2,631.40 | 6.54 | 164 | -274.07 | 31.64 | |
156.04 | 3,651.54 | 764.75 | 1,584.46 | #1 27.51 | 10 | 98.20 | 40.77 | |
244.51 | 3,170.54 | 167.54 | 535.94 | 19.15 | 16 | #1 555.56 | 41.14 | |
1,449.90 | 2,409.89 | 16.45 | 1,241.84 | 3.57 | 150 | 52.19 | 52.09 |
Growth Rate
Revenue Growth
14.20 %
Net Income Growth
73.66 %
Cash Flow Change
31.84 %
ROE
-6.13 %
ROCE
-2.59 %
EBITDA Margin (Avg.)
44.59 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 27 | 87 | 89 | 91 | 88 | 81 | 77 | 100 | 127 | 141 | 155 |
| Fixed Assets | 2 | 2 | 3 | 8 | 8 | 12 | 14 | 16 | 22 | 24 | 24 |
| Current Assets | 25 | 84 | 81 | 81 | 77 | 69 | 63 | 83 | 105 | 116 | 130 |
| Capital Work in Progress | 0 | 0 | 0 | 2 | 3 | 0 | 0 | 1 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 63 |
| Other Assets | 25 | 85 | 86 | 81 | 77 | 69 | 63 | 83 | 106 | 117 | 0 |
| Total Equity & Liabilities | 27 | 87 | 89 | 91 | 88 | 81 | 77 | 100 | 127 | 141 | 155 |
| Current Liabilities | 24 | 78 | 70 | 72 | 65 | 56 | 51 | 60 | 84 | 96 | 103 |
| Non Current Liabilities | 0 | 5 | 11 | 7 | 11 | 12 | 11 | 10 | 10 | 8 | 8 |
| Total Equity | 3 | 5 | 9 | 11 | 12 | 13 | 15 | 30 | 34 | 37 | 45 |
| Reserve & Surplus | 2 | 4 | 8 | 6 | 7 | 8 | 10 | 23 | 27 | 31 | 38 |
| Share Capital | 1 | 1 | 1 | 5 | 5 | 5 | 5 | 7 | 7 | 7 | 7 |
Cash Flow
| Cash Flow | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | -0 | -0 | 0 | -0 | 0 | 1 | -1 | 1 |
| Investing Activities | 0 | -5 | -2 | -2 | -2 | -3 | -4 | -7 | -5 |
| Operating Activities | -4 | 1 | 8 | 1 | 2 | 7 | -3 | 8 | 10 |
| Financing Activities | 4 | 4 | -6 | 1 | -1 | -3 | 8 | -2 | -4 |
Share Holding
| % Holding | Apr 2022 | Jan 2022 | Mar 2023 | Sept 2023 | Mar 2024 | Sept 2024 | Mar 2025 | Sept 2025 | Mar 2026 |
| Promoter | 100.00 % | 73.37 % | 73.37 % | 73.37 % | 73.37 % | 73.37 % | 73.42 % | 73.42 % | 73.42 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 24.28 % | 22.14 % | 22.84 % | 24.18 % | 23.69 % | 23.10 % | 24.14 % | 24.28 % |
| Others | 0.00 % | 2.35 % | 4.49 % | 3.78 % | 2.44 % | 2.94 % | 3.48 % | 2.44 % | 2.30 % |
| No of Share Holders | 7 | 1,004 | 660 | 652 | 742 | 625 | 512 | 468 | 453 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 15 Sept 2023 |  Dividend | ₹ 0.25 /share | 15 Sept 2023 | 61.25 | 84.25 |
| 13 Sept 2024 | Dividend | ₹ 0.40 /share | 13 Sept 2024 | 79.25 | 106.25 |
| 20 Sept 2024 |  Annual General Meeting | NA | 20 Sept 2024 | 102.00 | 107.00 |
| 14 Nov 2024 |  Quarterly Result Announcement | NA | 14 Nov 2024 | 159.00 | 137.75 |
| 29 May 2025 | Quarterly Result Announcement | NA | 29 May 2025 | 124.00 | 124.00 |
| 01 Sept 2025 | Dividend | ₹ 0.50 /share | 01 Sept 2025 | 124.00 | 120.60 |
| 14 Nov 2025 | Quarterly Result Announcement | NA | 14 Nov 2025 | 128.00 | 133.65 |
| 30 May 2026 | Quarterly Result Announcement | NA | 30 May 2026 | 115.90 | 109.80 |
Technical Indicators
RSI(14)
Neutral 54.47
ATR(14)
Less Volatile 4.42
STOCH(9,6)
Neutral 52.97
STOCH RSI(14)
Neutral 26.96
MACD(12,26)
Bullish 0.75
ADX(14)
Strong Trend 25.66
UO(9)
Bearish 51.07
ROC(12)
Uptrend And Accelerating 10.91
WillR(14)
Neutral -45.77
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
